BCL6 and neoplasm: Loss of Bcl6 accordingly skews macrophages to glycolytic catabolism and pro-inflammatory phenotype, which tends to cause metabolic competition between TAMs and tumor cells, placing macrophages at proliferation and survival disadvantage in expanding tumors.